Dexcom
CA · 12 filings, 2025
What the money shows
Dexcom reported $1.3M in federal lobbying for 2025 across 12 filings. The filings name 3 lobbying firms, led by Farragut Partners and Dexcom. The filing text lists 3 issue areas.
Sources: Senate LDA · FEC
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland. via Wikipedia ↗
1Lobbies on
Its filings list: Medicare/Medicaid · Health Issues · Trade (domestic/foreign)
2Through these firms · 3
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5237A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a comp…
- S 5242A bill to provide for digital communication of prescribing information for drugs (including biological prod…
- HR 10033Rules for self-driving cars and emergency crews